|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:application
|
Brain research
Enhancing memory
Controlling devices with thoughts
Restoring sensory functions
Treating neurological disorders
|
|
gptkbp:ceo
|
gptkb:Elon_Musk
|
|
gptkbp:collaborations
|
Academic institutions
Research organizations
Healthcare providers
Technology companies
|
|
gptkbp:focus
|
Medical applications
Cognitive enhancement
|
|
gptkbp:founded
|
gptkb:2016
|
|
gptkbp:founder
|
gptkb:Elon_Musk
|
|
gptkbp:goal
|
Developing implantable brain–machine interfaces
|
|
gptkbp:headquarters
|
gptkb:San_Francisco,_California
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Neuralink Corporation
|
|
gptkbp:industry
|
Neurotechnology
|
|
gptkbp:investment
|
gptkb:Y_Combinator
gptkb:DFJ
gptkb:Khosla_Ventures
gptkb:Founders_Fund
gptkb:Google_Ventures
|
|
gptkbp:key_people
|
gptkb:Ben_Rapoport
gptkb:Max_Hodak
|
|
gptkbp:notable_achievement
|
Demonstrated device in pigs
FDA approval for human trials
First human trials planned
Public demonstration in 2020
|
|
gptkbp:partnership
|
gptkb:University_of_California,_San_Francisco
|
|
gptkbp:products
|
gptkb:region
|
|
gptkbp:receives_funding_from
|
$363 million
|
|
gptkbp:regulatory_compliance
|
gptkb:FDA
|
|
gptkbp:research
|
gptkb:Artificial_Intelligence
Neuroscience
|
|
gptkbp:technology
|
gptkb:Neural_lace
gptkb:Robotic_surgery_system
Wireless communication
Flexible threads
Neural recording
Neural stimulation
|
|
gptkbp:type
|
Private company
|
|
gptkbp:vision
|
Enhancing human capabilities
Creating a direct communication pathway between brain and devices
Addressing brain-related diseases
Symbiosis between humans and AI
|
|
gptkbp:website
|
neuralink.com
|
|
gptkbp:bfsParent
|
gptkb:Neuralink_brain-machine_interface
gptkb:Neuralink_Brain-Machine_Interface
|
|
gptkbp:bfsLayer
|
4
|